The Open UniversitySkip to content
 

Biosimilars and the long game

Huzair, Farah and Kale, Dinar (2015). Biosimilars and the long game. Trends in Biotechnology, 33(5) pp. 250–252.

Full text available as:
Full text not publicly available
Due to copyright restrictions, this file is not available for public download
URL: http://www.sciencedirect.com/science/article/pii/S...
DOI (Digital Object Identifier) Link: https://doi.org/10.1016/j.tibtech.2015.01.001
Google Scholar: Look up in Google Scholar

Abstract

Despite greater certainty for biosimilar markets and regulation, the change that was seen in the small-molecule pharmaceuticals market with the rapid entrance of emerging-country generics suppliers will not be replicated exactly. The long game has yet to be played out, and recent changes in regulation, science, and production technology are likely to impact on future patterns of partnership and production.

Item Type: Journal Item
Copyright Holders: 2015 Elsevier Ltd.
ISSN: 1879-3096
Keywords: biosimilars; health; India; pharmaceutical industry; follow-on biologic; subsequent entry biologic
Academic Unit/School: Faculty of Science, Technology, Engineering and Mathematics (STEM) > Engineering and Innovation
Faculty of Science, Technology, Engineering and Mathematics (STEM)
Faculty of Arts and Social Sciences (FASS) > Politics, Philosophy, Economics, Development, Geography
Faculty of Arts and Social Sciences (FASS)
Interdisciplinary Research Centre: Innovation, Knowledge & Development research centre (IKD)
International Development & Inclusive Innovation
Item ID: 42557
Depositing User: Dinar Kale
Date Deposited: 22 Apr 2015 14:16
Last Modified: 10 Feb 2017 12:24
URI: http://oro.open.ac.uk/id/eprint/42557
Share this page:

Altmetrics

Actions (login may be required)

Policies | Disclaimer

© The Open University   contact the OU